110 related articles for article (PubMed ID: 26640585)
1. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.
Kim SK; Chung JH; Park HC; Kim JH; Ann JH; Park HK; Lee SH; Yoo KH; Lee BC; Kim YO
Exp Ther Med; 2015 Nov; 10(5):1990-1994. PubMed ID: 26640585
[TBL] [Abstract][Full Text] [Related]
2. Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
Ban JY; Yoo KH
Int Neurourol J; 2014 Jun; 18(2):63-7. PubMed ID: 24987558
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 10-1-6 gene cluster polymorphisms are not associated with benign prostatic hyperplasia in korean population.
Kim SK; Kim YO; Lee BC; Yoo KH; Chung JH
Int Neurourol J; 2014 Mar; 18(1):10-5. PubMed ID: 24729922
[TBL] [Abstract][Full Text] [Related]
4. Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.
Kim SK; Park HK; Choi HS; Yoo KH; Chung JH
Int Neurourol J; 2016 Dec; 20(4):363-370. PubMed ID: 28043105
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
Yoo KH; Kim SK; Chung JH; Chang SG
Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
[TBL] [Abstract][Full Text] [Related]
7. Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.
Wu H; Xu L; Chen J; Hu J; Yu S; Hu G; Huang L; Chen X; Yuan X; Li G
BMC Cancer; 2012 Jul; 12():276. PubMed ID: 22759347
[TBL] [Abstract][Full Text] [Related]
8. Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population.
Cho AR; Lee SM; Kang WS; Kim SK; Chung JH
Clin Psychopharmacol Neurosci; 2012 Aug; 10(2):88-93. PubMed ID: 23429213
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
Yu KD; Rao NY; Chen AX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 126(1):37-45. PubMed ID: 20390341
[TBL] [Abstract][Full Text] [Related]
10. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.
Zhao Q; Lee JH; Pang D; Temkin A; Park N; Janicki SC; Zigman WB; Silverman W; Tycko B; Schupf N
Dement Geriatr Cogn Disord; 2011; 32(4):241-9. PubMed ID: 22156442
[TBL] [Abstract][Full Text] [Related]
12.
Gallegos-Arreola MP; Zúñiga-González GM; Figuera LE; Puebla-Pérez AM; Márquez-Rosales MG; Gómez-Meda BC; Rosales-Reynoso MA
PeerJ; 2022; 10():e13379. PubMed ID: 35573183
[TBL] [Abstract][Full Text] [Related]
13. Association between a Missense Polymorphism (rs3924999, Arg253Gln) of Neuregulin 1 and Schizophrenia in Korean Population.
Yang SA
Exp Neurobiol; 2012 Dec; 21(4):158-63. PubMed ID: 23319876
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
15. Association study between growth hormone receptor (
Yang SA
J Exerc Rehabil; 2016 Dec; 12(6):632-636. PubMed ID: 28119888
[TBL] [Abstract][Full Text] [Related]
16. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
17. Association of single-nucleotide polymorphisms in the ESR2 and FSHR genes with poor ovarian response in infertile Jordanian women.
Sindiani AM; Batiha O; Al-Zoubi E; Khadrawi S; Alsoukhni G; Alkofahi A; Alahmad NA; Shaaban S; Alshdaifat E; Abu-Halima M
Clin Exp Reprod Med; 2021 Mar; 48(1):69-79. PubMed ID: 33503363
[TBL] [Abstract][Full Text] [Related]
18. Association between estrogen receptor β polymorphisms and prostate cancer in a Slovak population.
Jurečeková J; Sivoňová MK; Drobková H; Híveš M; Evin D; Kliment J; Dobrota D
Oncol Lett; 2021 Mar; 21(3):214. PubMed ID: 33510815
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
20. Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.
Glaser A; Shi Z; Wei J; Lanman NA; Ladson-Gary S; Vickman RE; Franco OE; Crawford SE; Lilly Zheng S; Hayward SW; Isaacs WB; Helfand BT; Xu J
Eur Urol Open Sci; 2022 Sep; 43():54-61. PubMed ID: 36353071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
